News Brief: FDA CDER Director Patrizia Cavazzoni Announces …
Jan 10, 2025 · Several media outlets have reported the planned resignation of U.S. FDA Center for Drug Evaluation and Research (CDER) Director Patrizia Cavazzoni, effective January 18, …
FDA Proposes Ending Use of Oral Phenylephrine as OTC …
FDA is proposing to end the use of oral phenylephrine as an active ingredient from OTC Monograph M012 for the temporary relief of nasal congestion because the agency determined …
FDA's Patrizia Cavazzoni to retire as CDER chief
Jan 10, 2025 · The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire from the agency. The seven-year FDA veteran …
Patrizia Cavazzoni, key FDA official, to leave agency
Jan 10, 2025 · Patrizia Cavazzoni, an influential Food and Drug Administration official who oversees much of the agency’s drug review work, will leave her role next week, according to …
FDA drug center head Patrizia Cavazzoni leaving agency - STAT
Jan 10, 2025 · Patrizia Cavazzoni, leader of the Food and Drug Administration’s Center for Drug Evaluation and Research, is leaving the agency on Jan. 18, the latest top official to exit as …
FDA CDER director Patrizia Cavazzoni announces resignation
Jan 10, 2025 · The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research (CDER), Patrizia Cavazzoni, has announced her …
Cavazzoni Retires as CDER Director - pharmtech.com
Jan 10, 2025 · An email communication, dated Jan. 10, 2025, released by FDA’s Center for Drug Evaluation and Research (CDER), announced the retirement of CDER Director, Patrizia …
What CDER Director Patrizia Cavazzoni’s retirement means for FDA
Jan 10, 2025 · PATRIZIA CAVAZZONI, the country’s top drug regulator, announced today that she will retire from her position as director of the FDA’s Center for Drug Evaluation and …
CDER director Cavazzoni is second FDA leader to step down in …
Jan 10, 2025 · Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research (CDER), said Friday that she will retire on Jan. 18 after leading the US regulator's drug …
Cavazzoni calls for ultrarare pathway at FDA, reforms to complex ...
4 days ago · Cavazzoni emphasized that she was describing her personal views based on seven years at FDA, including almost five years as CDER director or acting director. Her comments …
- Some results have been removed